"Random high" trial data misleads; BioClinica to consume TranSenda;

> In trials ended early due to better-than-expected results, researchers may have caught data at a "random high"--the appearance of a big effect that may lessen over time. Article

> Service provider BioClinica is acquiring TranSenda, maker of the MS Office-interoperable Office-Smart clinical trial management system. Release

> Both trial recruitment and retention materials need to evoke an emotional response, but retention messages must also reinforce a tie to the study and show subjects the significance of their commitment. Article

> An unnamed tissue-regeneration company is randomizing subjects and collecting data in the operating room via DATATRAK's eClinical platform. Announcement

> A Tufts study says the workload for pharma regulatory affairs professionals has "dramatically increased." Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.